#1 Clinical Trials Search in Europe

Calcipotriol

This article summarizes recent clinical trials investigating the use of calcipotriol, a vitamin D analog, for treating different skin conditions. Calcipotriol has shown promise in managing psoriasis, actinic keratosis, and other dermatological issues. The trials explore its efficacy alone and in combination with other treatments.

Table of Contents

What is Calcipotriol?

Calcipotriol, also known by its brand name Dovonex, is a medication used to treat various skin conditions[1]. It belongs to a class of drugs called vitamin D analogues, which means it’s a synthetic form of vitamin D[2]. Calcipotriol is typically used as a topical treatment, which means it’s applied directly to the skin.

What Conditions Does Calcipotriol Treat?

Calcipotriol is primarily used to treat the following conditions:

  • Psoriasis: This is the most common condition treated with calcipotriol. Psoriasis is a chronic autoimmune condition that causes rapid buildup of skin cells, resulting in scaly, itchy, dry patches on the skin[3].
  • Alopecia Areata: Some studies are investigating the use of calcipotriol for this condition, which causes patchy hair loss[4].
  • Actinic Keratoses: These are rough, scaly patches on the skin caused by years of sun exposure. Research is being conducted on using calcipotriol as part of a treatment for this condition[5].

How Does Calcipotriol Work?

Calcipotriol works in several ways to improve skin conditions:

  1. It slows down the rapid growth of skin cells, which is particularly helpful in psoriasis[3].
  2. It helps regulate the differentiation (maturation) of skin cells, promoting healthier skin growth[4].
  3. It has anti-inflammatory effects, which can help reduce redness and swelling associated with skin conditions[1].
  4. In the case of alopecia areata, it may help regulate the immune system’s response in the hair follicles[4].

How is Calcipotriol Administered?

Calcipotriol is typically applied topically (on the skin) in the form of a cream, ointment, or solution. The usual dosage is to apply it once or twice daily to the affected areas of skin[6]. It’s important to follow your doctor’s instructions carefully when using calcipotriol.

Effectiveness of Calcipotriol

Studies have shown that calcipotriol can be effective in treating psoriasis. In clinical trials, many patients experienced significant improvement in their psoriasis symptoms after using calcipotriol[3]. The effectiveness is often measured using scales like the Psoriasis Area and Severity Index (PASI), which assesses the extent and severity of psoriasis[7].

Combination Therapies with Calcipotriol

Calcipotriol is often used in combination with other treatments to enhance its effectiveness:

  • Calcipotriol and Betamethasone: This combination is commonly used for psoriasis treatment. Betamethasone is a corticosteroid that helps reduce inflammation[3].
  • Calcipotriol and Nicotinamide: Some studies are looking at combining calcipotriol with nicotinamide (a form of vitamin B3) for psoriasis treatment[1].
  • Calcipotriol and Photodynamic Therapy (PDT): Research is being conducted on using calcipotriol as a pre-treatment before PDT for actinic keratoses[5].

Potential Side Effects

While calcipotriol is generally well-tolerated, it can cause some side effects. Common side effects may include:

  • Skin irritation
  • Burning or stinging sensation
  • Redness
  • Itching

These side effects are usually mild and tend to improve as your body adjusts to the medication. If you experience severe or persistent side effects, you should contact your healthcare provider[2].

Ongoing Research and Future Directions

Research on calcipotriol is ongoing, with scientists exploring its potential in treating various conditions:

  • Its use in alopecia areata treatment is being studied, with researchers investigating how it affects hair regrowth and serum adiponectin levels (a protein involved in regulating glucose levels and fatty acid breakdown)[4].
  • The potential of calcipotriol as a radioprotector for the skin during radiotherapy is being explored[8].
  • Its role in treating actinic keratoses, especially when used before photodynamic therapy, is under investigation[5].

These ongoing studies may lead to new applications for calcipotriol in the future, potentially expanding its use in dermatology and other medical fields.

Condition Treatment Key Findings
Psoriasis Calcipotriol alone or combined with betamethasone Effective in reducing psoriasis severity, often measured by PASI scores
Actinic Keratosis Calcipotriol as pre-treatment for photodynamic therapy Being compared to 5-fluorouracil for efficacy in enhancing PDT outcomes
Alopecia Areata Topical calcipotriol Under investigation for potential hair regrowth effects
Radioprotection Topical calcipotriol before radiotherapy Being studied for potential protective effects on skin during breast cancer radiotherapy
Allergic Contact Dermatitis Calcipotriol for nickel desensitization Exploring potential to reduce skin sensitivity in nickel-allergic patients

FAQ

  • What skin conditions is calcipotriol being studied for? Calcipotriol is being studied for several skin conditions, including psoriasis, actinic keratosis, alopecia areata, and as a potential radioprotector for skin during radiotherapy.
  • How is calcipotriol typically administered in these trials? In most trials, calcipotriol is administered topically as a cream or ointment, usually applied once or twice daily to the affected areas of skin.
  • What are some common combinations being tested with calcipotriol? Common combinations being tested include calcipotriol with betamethasone dipropionate (a corticosteroid), nicotinamide, and as a pre-treatment before photodynamic therapy.
  • How long do the calcipotriol treatments typically last in these trials? Treatment durations vary by study, but many trials last between 4 to 12 weeks, with some extending follow-up to 6 months or a year to assess long-term effects.
  • What are some of the primary outcomes being measured in these trials? Primary outcomes often include reduction in disease severity (e.g., Psoriasis Area and Severity Index scores), complete clearance of lesions, patient-reported outcomes like pain or quality of life, and safety assessments.

Ongoing Clinical Trials on Calcipotriol

  • Study on 5-Fluorouracil and Calcipotriol for Treating Actinic Keratosis in Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Calcipotriol: A synthetic vitamin D analog used topically to treat various skin conditions, particularly psoriasis. It works by slowing down the growth of skin cells and reducing inflammation.
  • Psoriasis: A chronic autoimmune condition that causes rapid buildup of skin cells, resulting in scaly, itchy, dry patches on the skin.
  • Actinic Keratosis: A rough, scaly patch on the skin caused by years of sun exposure, which can potentially develop into skin cancer.
  • Alopecia Areata: An autoimmune disorder causing hair loss in patches on the scalp or other parts of the body.
  • Photodynamic Therapy (PDT): A treatment that uses light-sensitive medication and a light source to destroy abnormal cells, often used for skin conditions.
  • Betamethasone: A potent corticosteroid medication used to reduce inflammation and suppress the immune response in various skin conditions.
  • PASI (Psoriasis Area and Severity Index): A tool used to measure the severity and extent of psoriasis, considering factors like redness, thickness, and scaling of lesions.
  • Radioprotector: A substance that provides protection against the harmful effects of ionizing radiation, in this context, for the skin during radiotherapy.
  • Nicotinamide: A form of vitamin B3 that has shown potential benefits in treating various skin conditions when used topically or orally.
  • Trichoscopy: A non-invasive method of examining hair and scalp using a special magnifying device, often used in diagnosing and monitoring hair disorders.

References

  1. https://clinicaltrials.gov/study/NCT01763424
  2. https://clinicaltrials.gov/study/NCT01413477
  3. https://clinicaltrials.gov/study/NCT00216892
  4. https://clinicaltrials.gov/study/NCT05954104
  5. https://clinicaltrials.gov/study/NCT06685588
  6. https://clinicaltrials.gov/study/NCT00705900
  7. https://clinicaltrials.gov/study/NCT02191007
  8. https://clinicaltrials.gov/study/NCT00445250